A novel approach to detecting microduplication in split hand/foot malformation type 3 at the single-cell level: SHFM as a case study.


Journal

Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602

Informations de publication

Date de publication:
31 Oct 2024
Historique:
received: 24 05 2024
accepted: 25 09 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 1 11 2024
Statut: epublish

Résumé

Split hand/foot malformation (SHFM) is a congenital limb deficiency characterized by missing or shortened central digits. Several gene loci have been associated with SHFM. Identifying microduplications at the single-cell level is challenging in clinical practice, and traditional detection methods may lead to misdiagnoses in embryos and pregnant women. In this research, we utilized a low cell count and whole-genome amplification products to employ single nucleotide polymorphism arrays, next-generation sequencing, and third-generation sequencing methods to detect copy number variants of microduplications in a SHFM3 case with limited DNA. Additionally, Karyomapping and combined linkage analysis were conducted to validate the results. This study establishes a new strategy for identifying microduplications or microdeletions at the single-cell level in clinical preimplantation genetic testing, enhancing the efficiency and accuracy of diagnosing microduplication or microdeletion diseases during IVF-PGT and prenatal diagnosis.

Sections du résumé

BACKGROUND BACKGROUND
Split hand/foot malformation (SHFM) is a congenital limb deficiency characterized by missing or shortened central digits. Several gene loci have been associated with SHFM. Identifying microduplications at the single-cell level is challenging in clinical practice, and traditional detection methods may lead to misdiagnoses in embryos and pregnant women.
RESULTS RESULTS
In this research, we utilized a low cell count and whole-genome amplification products to employ single nucleotide polymorphism arrays, next-generation sequencing, and third-generation sequencing methods to detect copy number variants of microduplications in a SHFM3 case with limited DNA. Additionally, Karyomapping and combined linkage analysis were conducted to validate the results.
CONCLUSIONS CONCLUSIONS
This study establishes a new strategy for identifying microduplications or microdeletions at the single-cell level in clinical preimplantation genetic testing, enhancing the efficiency and accuracy of diagnosing microduplication or microdeletion diseases during IVF-PGT and prenatal diagnosis.

Identifiants

pubmed: 39482735
doi: 10.1186/s13023-024-03386-5
pii: 10.1186/s13023-024-03386-5
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

406

Subventions

Organisme : National Key R&D program
ID : 2019YFA0802200
Organisme : Innovative Research Group Project of the National Natural Science Foundation of China
ID : 32170819
Organisme : joint fund for the cultivation of superior displines
ID : 222301420013
Organisme : Henan Province University science and technology innovation team
ID : 24IRTSTHN037

Informations de copyright

© 2024. The Author(s).

Références

Czeizel AE, et al. An epidemiological study of isolated split hand/foot in Hungary, 1975–1984. J Med Genet. 1993;30(7):593–6.
doi: 10.1136/jmg.30.7.593 pubmed: 8411034 pmcid: 1016461
Dai L, et al. Prevalence of congenital split hand/split foot malformation in Chinese population. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010;41(2):320–3.
pubmed: 20506663
Velinov M, et al. A 0.7 Mb de novo duplication at 7q21.3 including the genes DLX5 and DLX6 in a patient with split-hand/split-foot malformation. Am J Med Genet A. 2012;158A(12):3201–6.
doi: 10.1002/ajmg.a.35644 pubmed: 23169702
Sowinska-Seidler A, Socha M, Jamsheer A. Split-hand/foot malformation—molecular cause and implications in genetic counseling. J Appl Genet. 2014;55(1):105–15.
doi: 10.1007/s13353-013-0178-5 pubmed: 24163146
Dai L, et al. Discontinuous microduplications at chromosome 10q24.31 identified in a Chinese family with split hand and foot malformation. BMC Med Genet. 2013;14:45.
doi: 10.1186/1471-2350-14-45 pubmed: 23596994 pmcid: 3637097
Sulik KK, Dehart DB. Retinoic-acid-induced limb malformations resulting from apical ectodermal ridge cell death. Teratology. 1988;37(6):527–37.
doi: 10.1002/tera.1420370602 pubmed: 3165225
Scherer SW, et al. Fine mapping of the autosomal dominant split hand/split foot locus on chromosome 7, band q21.3–q22.1. Am J Hum Genet. 1994;55(1):12–20.
pubmed: 8023840 pmcid: 1918243
Gurrieri F, Everman DB. Clinical, genetic, and molecular aspects of split-hand/foot malformation: an update. Am J Med Genet A. 2013;161A(11):2860–72.
doi: 10.1002/ajmg.a.36239 pubmed: 24115638
Sivasankaran A, et al. Split hand/foot malformation associated with 7q21.3 microdeletion: a case report. Mol Syndromol. 2016;6(6):287–96.
doi: 10.1159/000443708 pubmed: 27022330 pmcid: 4802982
Shamseldin HE, et al. Identification of a novel DLX5 mutation in a family with autosomal recessive split hand and foot malformation. J Med Genet. 2012;49(1):16–20.
doi: 10.1136/jmedgenet-2011-100556 pubmed: 22121204
van Silfhout AT, et al. Split hand/foot malformation due to chromosome 7q aberrations(SHFM1): additional support for functional haploinsufficiency as the causative mechanism. Eur J Hum Genet. 2009;17(11):1432–8.
doi: 10.1038/ejhg.2009.72 pubmed: 19401716 pmcid: 2986677
Faiyaz-Ul-Haque M, et al. Fine mapping of the X-linked split-hand/split-foot malformation (SHFM2) locus to a 5.1-Mb region on Xq26.3 and analysis of candidate genes. Clin Genet. 2005;67(1):93–7.
doi: 10.1111/j.1399-0004.2004.00369.x pubmed: 15617554
Faiyaz ul Haque M, et al. Mapping of the gene for X-chromosomal split-hand/split-foot anomaly to Xq26-q26.1. Hum Genet. 1993;91(1):17–9.
doi: 10.1007/BF00230215 pubmed: 8454282
Qiu L, et al. Microduplication of BTRC detected in a Chinese family with split hand/foot malformation type 3. Clin Genet. 2022;102(5):451–6.
doi: 10.1111/cge.14204 pubmed: 35908152
Ianakiev P, et al. Split-hand/split-foot malformation is caused by mutations in the p63 gene on 3q27. Am J Hum Genet. 2000;67(1):59–66.
doi: 10.1086/302972 pubmed: 10839977 pmcid: 1287102
Koster MI, et al. p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev. 2004;18(2):126–31.
doi: 10.1101/gad.1165104 pubmed: 14729569 pmcid: 324418
Boles RG, et al. Deletion of chromosome 2q24-q31 causes characteristic digital anomalies: case report and review. Am J Med Genet. 1995;55(2):155–60.
doi: 10.1002/ajmg.1320550204 pubmed: 7717414
Goodman FR, et al. A 117-kb microdeletion removing HOXD9-HOXD13 and EVX2 causes synpolydactyly. Am J Hum Genet. 2002;70(2):547–55.
doi: 10.1086/338921 pubmed: 11778160 pmcid: 384929
Khan S, et al. A novel homozygous missense mutation in WNT10B in familial split-hand/foot malformation. Clin Genet. 2012;82(1):48–55.
doi: 10.1111/j.1399-0004.2011.01698.x pubmed: 21554266
Blattner A, Huber AR, Rothlisberger B. Homozygous nonsense mutation in WNT10B and sporadic split-hand/foot malformation (SHFM) with autosomal recessive inheritance. Am J Med Genet A. 2010;152A(8):2053–6.
doi: 10.1002/ajmg.a.33504 pubmed: 20635353
Lezirovitz K, et al. A novel locus for split-hand/foot malformation associated with tibial hemimelia (SHFLD syndrome) maps to chromosome region 17p13.1–17p13.3. Hum Genet. 2008;123(6):625–31.
doi: 10.1007/s00439-008-0515-7 pubmed: 18493797
Volozonoka L, Miskova A, Gailite L. Whole genome amplification in preimplantation genetic testing in the era of massively parallel sequencing. Int J Mol Sci. 2022;23(9):4819.
doi: 10.3390/ijms23094819 pubmed: 35563216 pmcid: 9102663
Xie P, et al. A novel multifunctional haplotyping-based preimplantation genetic testing for different genetic conditions. Hum Reprod. 2022;37(11):2546–59.
doi: 10.1093/humrep/deac190 pubmed: 36066440
Geraedts J, Sermon K. Preimplantation genetic screening 2.0: the theory. Mol Hum Reprod. 2016;22(8):839–44.
doi: 10.1093/molehr/gaw033 pubmed: 27256482 pmcid: 4986416
Xie P, et al. Segmental aneuploidies with 1 Mb resolution in human preimplantation blastocysts. Genet Med. 2022;24(11):2285–95.
doi: 10.1016/j.gim.2022.08.008 pubmed: 36107168
Sabria-Back J, et al. Preimplantation genetic testing for a chr14q32 microdeletion in a family with Kagami-Ogata syndrome and Temple syndrome. J Med Genet. 2022;59(3):253–61.
doi: 10.1136/jmedgenet-2020-107433 pubmed: 33579810
Girirajan S, et al. Phenotypic heterogeneity of genomic disorders and rare copy-number variants. N Engl J Med. 2012;367(14):1321–31.
doi: 10.1056/NEJMoa1200395 pubmed: 22970919 pmcid: 3494411
Yan L, et al. Live births after simultaneous avoidance of monogenic diseases and chromosome abnormality by next-generation sequencing with linkage analyses. Proc Natl Acad Sci U S A. 2015;112(52):15964–9.
doi: 10.1073/pnas.1523297113 pubmed: 26712022 pmcid: 4702982
Richards S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.
doi: 10.1038/gim.2015.30 pubmed: 25741868 pmcid: 4544753
den Dunnen JT. Sequence variant descriptions: HGVS nomenclature and mutalyzer. Curr Protoc Hum Genet. 2016;90:7–13.
Kearney HM, et al. American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants. Genet Med. 2011;13(7):680–5.
doi: 10.1097/GIM.0b013e3182217a3a pubmed: 21681106
Brown S. Identity-by-state analysis: a new method for PGT-M. Hum Reprod. 2020;35(3):485–7.
doi: 10.1093/humrep/deaa011 pubmed: 32198500

Auteurs

Yaqian Wang (Y)

The First Affiliated Hospital, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University and Institute of Reproductive Health, Henan Academy of Innovations in Medical Science, Zhengzhou, China.
NHC Key Laboratory of Birth Defects Prevention, Zhengzhou, China.

Yang Li (Y)

The First Affiliated Hospital, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University and Institute of Reproductive Health, Henan Academy of Innovations in Medical Science, Zhengzhou, China.
NHC Key Laboratory of Birth Defects Prevention, Zhengzhou, China.

Lidong Zeng (L)

Shenzhen GeneMind Biosciences Co., Ltd, Shenzhen, China.

Wenbo Li (W)

The First Affiliated Hospital, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University and Institute of Reproductive Health, Henan Academy of Innovations in Medical Science, Zhengzhou, China.
NHC Key Laboratory of Birth Defects Prevention, Zhengzhou, China.

Xin Dong (X)

The First Affiliated Hospital, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University and Institute of Reproductive Health, Henan Academy of Innovations in Medical Science, Zhengzhou, China.
NHC Key Laboratory of Birth Defects Prevention, Zhengzhou, China.

Jia Guo (J)

The First Affiliated Hospital, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University and Institute of Reproductive Health, Henan Academy of Innovations in Medical Science, Zhengzhou, China.
NHC Key Laboratory of Birth Defects Prevention, Zhengzhou, China.

Xiangrui Meng (X)

The First Affiliated Hospital, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University and Institute of Reproductive Health, Henan Academy of Innovations in Medical Science, Zhengzhou, China.
NHC Key Laboratory of Birth Defects Prevention, Zhengzhou, China.

Jiacheng Lu (J)

The First Affiliated Hospital, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University and Institute of Reproductive Health, Henan Academy of Innovations in Medical Science, Zhengzhou, China.
NHC Key Laboratory of Birth Defects Prevention, Zhengzhou, China.

Jiawei Xu (J)

The First Affiliated Hospital, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University and Institute of Reproductive Health, Henan Academy of Innovations in Medical Science, Zhengzhou, China. jiawxu@foxmail.com.
NHC Key Laboratory of Birth Defects Prevention, Zhengzhou, China. jiawxu@foxmail.com.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH